Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
109.35
0.00
0.00
0.00
0.00
0.00
0.51
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
109.35
0.00
0.00
0.00
0.00
0.00
0.51
Raw Material Cost
0.00
3.42
3.61
3.60
3.54
1.34
21.76
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
89.43
78.31
59.17
33.30
34.22
8.07
13.12
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
0.01
0.01
0.03
0.00
Selling and Distribution Expenses
50.44
44.59
37.53
21.61
21.45
26.76
0.00
Other Expenses
15.76
19.46
18.72
23.49
10.78
5.77
0.73
Total Expenditure (Excl Depreciation)
297.46
320.89
287.49
293.42
167.01
93.92
42.22
Operating Profit (PBDIT) excl Other Income
-188.1
-320.90000000000003
-287.5
-293.4
-167
-93.9
-41.7
Other Income
21.48
9.56
-0.84
-1.18
3.90
0.07
3.46
Operating Profit (PBDIT)
-166.64
-307.90
-284.72
-291.00
-159.57
-92.51
-38.25
Interest
0.01
0.00
0.01
0.01
0.01
0.03
0.00
Exceptional Items
0.00
0.00
-0.47
-2.12
15.80
0.55
0.00
Gross Profit (PBDT)
0.00
-3.42
-3.61
-3.60
-3.54
-1.34
-21.25
Depreciation
2.24
3.42
3.61
3.60
3.54
1.34
0.01
Profit Before Tax
-168.89
-311.33
-288.81
-296.74
-147.31
-93.33
-38.25
Tax
-0.26
-0.38
-0.38
-0.25
-0.45
-0.24
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-168.63
-310.94
-288.42
-296.48
-146.86
-93.08
-21.68
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-168.63
-310.94
-288.42
-296.48
-146.86
-93.08
-21.68
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-168.63
-310.94
-288.42
-296.48
-146.86
-93.08
-21.68
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.5
0.5
0.5
0.5
0.5
0.5
0.5
Reserves
1,129.33
455.39
289.08
383.32
354.51
321.60
285.44
Earnings per share (EPS)
-1.23
-3.13
-3.89
-4.14
-2.63
-2.1
-0.92
Diluted Earnings per share
-1.23
-3.13
-3.89
-4.14
-2.63
-2.1
-0.92
Operating Profit Margin (Excl OI)
-174.09%
0.0%
0.0%
0.0%
0.0%
0.0%
-8210.83%
Gross Profit Margin
-152.4%
0.0%
0.0%
0.0%
0.0%
0.0%
-7528.94%
PAT Margin
-154.22%
0.0%
0.0%
0.0%
0.0%
0.0%
-4267.91%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 45.77% vs -7.80% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 40.76% vs -11.84% in Dec 2023
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
Compare Annual Results Of Vicore Pharma Holding AB With
Figures in Million
Consolidate Annual Results
Change(SEK)
Change(%)
Net Sales
109.35
171.32
-61.97
-36.17%
Other Operating Income
0.00
0.00
0.00
Total Operating income
109.35
171.32
-61.97
-36.17%
Raw Material Cost
0.00
93.64
-93.64
-100.00%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
89.43
342.49
-253.06
-73.89%
Power Cost
0
0
0.00
Manufacturing Expenses
0.01
121.43
-121.42
-99.99%
Selling and Distribution Expenses
50.44
336.52
-286.08
-85.01%
Other Expenses
15.76
-10.33
26.09
252.57%
Total Expenditure (Excl Depreciation)
297.46
790.74
-493.28
-62.38%
Operating Profit (PBDIT) excl Other Income
-188.12
-619.42
431.30
69.63%
Other Income
21.48
-50.56
72.04
142.48%
Operating Profit (PBDIT)
-166.64
-641.92
475.28
74.04%
Interest
0.01
121.43
-121.42
-99.99%
Exceptional Items
0.00
-12.80
12.80
100.00%
Gross Profit (PBDT)
0.00
77.68
-77.68
-100.00%
Depreciation
2.24
28.06
-25.82
-92.02%
Profit Before Tax
-168.89
-804.21
635.32
79.00%
Tax
-0.26
3.03
-3.29
-108.58%
Provisions and contingencies
0
0
0.00
Profit After Tax
-168.63
-807.24
638.61
79.11%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-168.63
-807.24
638.61
79.11%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-168.63
-807.24
638.61
79.11%
Equity Capital
0
0
0.00
Face Value
0.50
1.00
0.00
Reserves
1,129.33
-589.83
1,719.16
291.47%
Earnings per share (EPS)
-1.23
-12.85
11.62
90.43%
Diluted Earnings per share
-1.23
-12.85
11.62
90.43%
Operating Profit Margin (Excl OI)
-174.09%
-361.57%
0.00
187.48%
Gross Profit Margin
-152.40%
-453.05%
0.00
300.65%
PAT Margin
-154.22%
-471.20%
0.00
316.98%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 10.93 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit -16.86 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 45.77% vs -7.80% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -18.81 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 40.76% vs -11.84% in Dec 2023
Annual - Interest
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -174.09%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has fallen from Dec 2023






